Analyses based on microarray and RNA-seq technologies, respectively, revealed that ER positive breast tumors expressed the lowest FAT1 levels while those cases lacking ER showed higher FAT1 expression (Fig. S2A, B). The gene discussed is ESR1; the disease is breast neoplasm.